Journal
PEPTIDES
Volume 26, Issue 11, Pages 2252-2256Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.peptides.2005.04.011
Keywords
corticotropin-releasing factor (CRF); CRH; paraventricular nucleus (PVN); median eminence (ME); immunoblot; Western blot; colchicine; HPA axis
Funding
- NIMH NIH HHS [MH63266] Funding Source: Medline
Ask authors/readers for more resources
The ability to measure changes in brain levels of corticotropin-releasing factor (CRF) is an important step toward understanding the role of this neuropeptide in mood states. Here, we report for the first time that the protein (Western) immunoblot assay can be used to detect and quantify CRF (4.7 kDa) from the rat brain. Intracerebroventricular (ICV) injections of the neuronal transport-inhibitor colchicine (0, 7.5, 15 and 75 mu g) produced a dose-dependent increase in CRF levels within the paraventricular nucleus (PVN) of the hypothalamus with a concomitant and dose-dependent decrease in CRF levels within the median eminence (ME). These data provide a positive validation for the use of the immunoblot assay to detect treatment-induced changes in brain CRF levels. (c) 2005 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available